My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2014
Top Story
Updated Guideline for Vaccination of Immunocompromised Host Now Available
IDSA has updated its Guideline for the Vaccination of the Immunocompromised Host in an effort to make it easier for clinicians to rapidly find vaccine recommendations for this patient population. The ultimate goal is to decrease morbidity and mortality from vaccine-preventable infections in immunocompromised patients.  
 
The guideline recommends that primary care clinicians and subspecialty providers share responsibility for ensuring appropriate vaccination of these patients. Vaccination of children and adults with primary immunodeficiencies are discussed, as are patients with a secondary deficiency including HIV infection, cancer treatment, stem cell or solid organ transplant, asplenia, cochlear implant, CSF leak, and patients with chronic inflammatory diseases treated with immunosuppressive therapies. Vaccinations of immunocompetent contacts of patients who have defense abnormalities and travel-related vaccination are also addressed. 
 
“The guideline provides ‘one-stop shopping’ for clinicians caring for children and adults with compromised immune systems and includes recommendations and evidence for most vaccinations, from influenza to chicken pox,” said Lorry G. Rubin, MD, FIDSA, lead author of the guideline. “Previously, the recommendations were difficult to retrieve because in most cases information had to be accessed individually by vaccine rather than by the category of patient disease.” Dr. Rubin is director of the Division of Pediatric Infectious Diseases at the Steven and Alexandra Cohen Children’s Medical Center of New York in New Hyde Park and professor of pediatrics at Hofstra North Shore-LIJ School of Medicine.
 
The vast majority of the recommendations contained in the guideline conform to recommendations of the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. The guideline provides recommendations for most vaccines, including the appropriate use of varicella and zoster vaccines, in easy-reference tables.
 
Areas where future research is warranted are outlined, such as establishment of a registry of immunocompromised vaccine recipients and research regarding the efficacy and safety of zoster vaccine in these patient populations.
 
The evidence-based guideline was prepared by an international panel of pediatric and adult experts in infectious diseases, immunology, oncology, stem cell and solid organ transplant, gastroenterology, and rheumatology.
 
The full guideline is available online and will also appear in the February 1 issue of Clinical Infectious Diseases. Visit the practice guidelines section of the IDSA website for additional guidelines and related resources.


< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
FDA Approves Simeprevir and Sofosbuvir for Chronic Hepatitis C
Policy and Advocacy
Congress Approves Partial Relief from Sequestration Funding Cuts
IDSA Supports Diagnostics Bill Moving through House of Representatives
IDSA and PIDS Submit Comments to FDA on Proposed Drug Shortage Rule
Congressional Briefing Highlights Barriers to Immunization for Older Adults
IDSA, SHEA, PIDS Call for Mandatory Immunization of Health Care Personnel
HIVMA Welcomes HIV Policy Assessment Directive in Defense Bill
President Obama Mentions Vaccines and Drug Resistance in State of the Union
Clinical Practice Management
New Resource Helps ID Specialists Prove Their Value
President Obama Signs Bill to Prevent Scheduled Medicare Cut
Science Speaks Blog
The Center for Global Health Policy Examines the Impact of Drug Prices on Vulnerable Populations, and Other Newsworthy Events
You and Your Colleagues
Renew Dues and Update Your Membership
Members on the Move
New Members
In Memoriam: Martin C. McHenry, MD, MS, FIDSA (1932-2013)
Education and Resources
Free Online Course on Antimicrobial Stewardship
Changes to ABIM MOC Now In Effect
Open Forum Infectious Diseases Now Accepting Submissions
Apply Now for the ID Research Careers Meeting
Top Story
From the President: New Website Provides Clinicians with Timely Advice on HCV
ADAPT Act Would Promote New Drug Development
Updated Guideline for Vaccination of Immunocompromised Host Now Available
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.